Cargando...
Sweet’s Syndrome Induced by Aromatase Inhibitor in the Treatment of Early Breast Cancer
BACKGROUND: Breast cancer is the most commonly diagnosed cancer in women, mainly at an early stage, allowing treatment with curative intent. Aromatase inhibitors are widely used in the adjuvant treatment of oestrogen receptor-positive breast cancer, mainly in postmenopausal women. The most frequent...
Guardado en:
| Publicado en: | Eur J Case Rep Intern Med |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
SMC Media Srl
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7083188/ https://ncbi.nlm.nih.gov/pubmed/32206641 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12890/2020_001435 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|